levodopa has been researched along with Ambulation Difficulty in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (40.00) | 29.6817 |
| 2010's | 6 (60.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Erbguth, F; Lange, R | 1 |
| Hortobágyi, T; Kovács, N; Nagy, F; Tollár, J | 1 |
| Daud, DB; McDonald, C | 1 |
| Bhakta, BB; Cozens, A; Farrin, AJ; Ford, GA; Hartley, S; Holloway, I; Meads, D; Pearn, J; Ruddock, S; Sackley, CM; Saloniki, EC; Santorelli, G; Walker, MF | 1 |
| Cavanaugh, JT; Dibble, LE; Earhart, GM; Ellis, TD; Ford, MP; Foreman, KB | 1 |
| Carlson-Kuhta, P; Horak, FB; Mancini, M; Nutt, JG; Salarian, A | 1 |
| Hatano, T; Hattori, N; Izawa, N; Kagohashi, M; Mizuno, Y; Mochizuki, H; Mori, H; Nishioka, K; Sato, K; Yamashiro, K | 1 |
| Huxham, F; Iansek, R; McGinley, J | 1 |
| Hagell, P; Nygren, C | 1 |
| Abe, T; Hasegawa, K; Kanazawa, I; Kondo, T; Kuno, S; Mizuno, Y; Nakashima, M; Yamamoto, M | 1 |
2 review(s) available for levodopa and Ambulation Difficulty
| Article | Year |
|---|---|
[Parkinson's disease in the elderly].
Topics: Aged; Aged, 80 and over; Antiparkinson Agents; Combined Modality Therapy; Community Integration; Comorbidity; Diagnosis, Differential; Disability Evaluation; Drug Therapy, Combination; Germany; Humans; Incidence; Levodopa; Mobility Limitation; Parkinson Disease; Quality of Life; Social Environment | 2017 |
Medical and surgical care for patients with Parkinson's disease.
Topics: Antiparkinson Agents; Catechol O-Methyltransferase Inhibitors; Constipation; Delirium; Dizziness; Dopamine Agonists; Hospitalization; Humans; Levodopa; Mobility Limitation; Monoamine Oxidase Inhibitors; Pain; Parkinson Disease | 2018 |
3 trial(s) available for levodopa and Ambulation Difficulty
| Article | Year |
|---|---|
A High-Intensity Multicomponent Agility Intervention Improves Parkinson Patients' Clinical and Motor Symptoms.
Topics: Activities of Daily Living; Aged; Disability Evaluation; Exercise Therapy; Feedback, Sensory; Female; Humans; Levodopa; Male; Middle Aged; Mobility Limitation; Motor Skills; Movement; Parkinson Disease; Photic Stimulation; Postural Balance; Research Design; Standing Position; Time and Motion Studies; Treatment Outcome | 2018 |
Safety and efficacy of co-careldopa as an add-on therapy to occupational and physical therapy in patients after stroke (DARS): a randomised, double-blind, placebo-controlled trial.
Topics: Adult; Aged; Aged, 80 and over; Brain Ischemia; Carbidopa; Dopamine Agents; Double-Blind Method; Drug Combinations; Female; Humans; Intracranial Hemorrhages; Levodopa; Male; Middle Aged; Mobility Limitation; Occupational Therapy; Physical Therapy Modalities; Prospective Studies; Stroke; Stroke Rehabilitation; Treatment Outcome | 2019 |
Ropinirole is effective on motor function when used as an adjunct to levodopa in Parkinson's disease: STRONG study.
Topics: Activities of Daily Living; Aged; Antiparkinson Agents; Case-Control Studies; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Indoles; Levodopa; Male; Middle Aged; Mobility Limitation; Neurologic Examination; Parkinson Disease; Treatment Outcome | 2007 |
5 other study(ies) available for levodopa and Ambulation Difficulty
| Article | Year |
|---|---|
Toward Understanding Ambulatory Activity Decline in Parkinson Disease.
Topics: Aged; Antiparkinson Agents; Disability Evaluation; Disease Progression; Female; Gait Disorders, Neurologic; Humans; Levodopa; Longitudinal Studies; Male; Mobility Limitation; Parkinson Disease; Postural Balance; Prospective Studies; Quality of Life; Self Efficacy; Surveys and Questionnaires; Upper Extremity | 2015 |
Balance and Gait Represent Independent Domains of Mobility in Parkinson Disease.
Topics: Aged; Antiparkinson Agents; Biomechanical Phenomena; Cross-Sectional Studies; Factor Analysis, Statistical; Female; Gait Disorders, Neurologic; Humans; Levodopa; Male; Mobility Limitation; Parkinson Disease; Postural Balance; Signal Processing, Computer-Assisted | 2016 |
Prognosis of Parkinson's disease: time to stage III, IV, V, and to motor fluctuations.
Topics: Adult; Age Factors; Aged; Antiparkinson Agents; Cohort Studies; Disability Evaluation; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Female; Humans; Japan; Levodopa; Male; Middle Aged; Mobility Limitation; Neurologic Examination; Parkinson Disease; Prognosis; Retrospective Studies; Severity of Illness Index; Sex Factors | 2006 |
The sequence effect and gait festination in Parkinson disease: contributors to freezing of gait?
Topics: Aged; Antiparkinson Agents; Attention; Basal Ganglia; Cues; Drug Therapy, Combination; Female; Gait Apraxia; Humans; Hypokinesia; Levodopa; Male; Middle Aged; Mobility Limitation; Neurologic Examination; Parkinson Disease; Risk Factors; Sensory Deprivation; Visual Perception; Walking | 2006 |
The 39 item Parkinson's disease questionnaire (PDQ-39) revisited: implications for evidence based medicine.
Topics: Activities of Daily Living; Adult; Aged; Aged, 80 and over; Antiparkinson Agents; Cognition Disorders; Disability Evaluation; Evidence-Based Medicine; Female; Geriatric Assessment; Humans; Levodopa; Male; Middle Aged; Mobility Limitation; Parkinson Disease; Psychometrics; Quality of Life; Reproducibility of Results; Sick Role; Surveys and Questionnaires; Sweden | 2007 |